iVIGA Tap Factory Birgir
Þessar þrjár salernisgreiningarheilsutækni verða klínískar prófaðar í Bandaríkjunum, Ísrael og Japan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 júní. The technology gains life-saving medical insights by analysing human excrement. Fyrirtækið hefur lagt fram röð af þremur einkaleyfum sem ná yfir þætti læknisfræðilegra salernisskynjara þess.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Evrópa, Japan og Kína.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Tækni OutSense getur greint uppruna blóðs meðfram meltingarveginum.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Að sögn Yfat Scialom, forstjóra OutSense, who predicts that “með sprengingu stafrænna lyfja, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, bólgusjúkdómar og þvagfærasýkingar.
Its solution consists of a multispectral optical sensor, ljósgjafi og sjálfstætt skimunartæki sem inniheldur WiFi tengingu. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Upplýsingar fengnar úr blóðsýni, ásamt viðbótargreiningu á tímanum frá blæðingu til útskilnaðar, veitir upplýsingar um blæðingarsjúkdóminn. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense tilkynnti að CommuniCare, stórt heilbrigðisfyrirtæki með meira en 90 healthcare facilities in the US, mun byrja að prufa tækni sína á þessu ári. Auk þessa flugmanns, OutSense also plans to conduct clinical trials in Israel and Japan.
Heimsæktu Fleiri fréttir á Viga.cc fréttir
